Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II - Related Studies

Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II

This study has been completed.

Study NCT00037388. Last updated on January 18, 2008. Information provided by National Heart, Lung, and Blood Institute (NHLBI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Blood Disease
		Anemia, Sickle Cell
		Chlamydia Infections
		Cerebrovascular Accident

2	Additional conditions recognized in this trial
		Anemia
		Cerebral Infarction
		Hematologic Diseases
		Infection
		Stroke

3	More general conditions related to this trial
		Anemia, Hemolytic
		Anemia, Hemolytic, Congenital
		Bacterial Infections
		Brain Diseases
		Brain Infarction
		Brain Ischemia
		Cardiovascular Diseases
		Central Nervous System Diseases
		Cerebrovascular Disorders
		Chlamydiaceae Infections
		Genetic Diseases, Inborn
		Genital Diseases, Female
		Genital Diseases, Male
		Gram-Negative Bacterial Infections
		Hemoglobinopathies
		Nervous System Diseases
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Bacterial
		Vascular Diseases

4	Sponsors listed in this trial
		National Heart, Lung, and Blood Institute (NHLBI)